NFL Biosciences SA (ALNFL.PA)
EUR 1.71
(1.07%)
EUR 1.71
(1.07%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 39.2 Thousand EUR | -52.91% |
| 2022 | 83.25 Thousand EUR | 1189271.43% |
| 2021 | 7.00 EUR | -99.99% |
| 2020 | 85 Thousand EUR | 0.0% |
| 2019 | - EUR | 0.0% |
| 2018 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 30.33 Thousand EUR | -22.63% |
| 2023 Q4 | 39.2 Thousand EUR | -46.1% |
| 2023 FY | 39.2 Thousand EUR | -52.91% |
| 2023 Q2 | 72.72 Thousand EUR | -12.65% |
| 2022 FY | 83.25 Thousand EUR | 1189271.43% |
| 2022 Q4 | 83.25 Thousand EUR | 17.31% |
| 2022 Q2 | 70.97 Thousand EUR | 0.0% |
| 2021 FY | 7.00 EUR | -99.99% |
| 2021 Q2 | 85 Thousand EUR | 0.0% |
| 2020 FY | 85 Thousand EUR | 0.0% |
| 2019 FY | - EUR | 0.0% |
| 2018 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| ABIONYX Pharma SA | 1.1 Million EUR | 96.439% |
| ABIVAX Société Anonyme | 44.69 Million EUR | 99.912% |
| Adocia SA | 4.54 Million EUR | 99.136% |
| Aelis Farma SA | 2.04 Million EUR | 98.086% |
| Biophytis S.A. | 3.11 Million EUR | 98.74% |
| Advicenne S.A. | 15.89 Million EUR | 99.753% |
| genOway Société anonyme | 5.51 Million EUR | 99.29% |
| IntegraGen SA | 642.28 Thousand EUR | 93.896% |
| Medesis Pharma S.A. | 1.2 Million EUR | 96.733% |
| Neovacs S.A. | 650 Thousand EUR | 93.969% |
| Plant Advanced Technologies SA | 4.35 Million EUR | 99.1% |
| Quantum Genomics Société Anonyme | 1.96 Million EUR | 98.0% |
| Sensorion SA | 1.24 Million EUR | 96.841% |
| Theranexus Société Anonyme | 2.46 Million EUR | 98.407% |
| TME Pharma N.V. | - EUR | -Infinity% |
| Valbiotis SA | 3.89 Million EUR | 98.994% |
| TheraVet SA | 1 Million EUR | 96.082% |
| Valerio Therapeutics Société anonyme | 6.9 Million EUR | 99.432% |
| DBV Technologies S.A. | 4.52 Million USD | 99.134% |
| Genfit S.A. | 62.25 Million EUR | 99.937% |
| GeNeuro SA | 6.49 Million EUR | 99.396% |
| Innate Pharma S.A. | 30.6 Million EUR | 99.872% |
| Inventiva S.A. | 25.61 Million EUR | 99.847% |
| MaaT Pharma SA | 5.42 Million EUR | 99.277% |
| MedinCell S.A. | 52.8 Million EUR | 99.926% |
| Nanobiotix S.A. | 41.66 Million EUR | 99.906% |
| OSE Immunotherapeutics SA | 35.5 Million EUR | 99.89% |
| Poxel S.A. | 40.14 Million EUR | 99.902% |
| GenSight Biologics S.A. | 1.04 Million EUR | 96.259% |
| Transgene SA | 17 Thousand EUR | -130.606% |
| Valneva SE | 132.76 Million EUR | 99.97% |